The management of gastrointestinal ALK-negative anaplastic large cell lymphoma remains challenging, with CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy serving as the historical standard regimen [14]. Here, ALK is linked to anaplastic large cell lymphoma.